GUTS

Fractyl Health

• TipRanks·03/28 00:30

  Fractyl Health Earnings Call: Revita Nears Key Pivotal Test

• Dow Jones·03/26 15:24

  Fractyl Health Is Maintained at Buy by Canaccord Genuity

• Dow Jones·03/26 15:24

  Fractyl Health Price Target Maintained With a $8.00/Share by Canaccord Genuity

• TipRanks·03/26 11:20

  Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Merck & Company (MRK) and Abbott Laboratories (ABT)

• TipRanks·03/26 06:00

  Fractyl Health Faces Significant Compliance Risks Under Global Anti-Corruption and Sanctions Laws

• TipRanks·03/25 14:40

  Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS) and Terns Pharmaceuticals (TERN)

• TipRanks·03/25 12:30

  Analysts Offer Insights on Healthcare Companies: Radiopharm Theranostics Limited Sponsored ADR (RADX), Alnylam Pharma (ALNY) and Fractyl Health, Inc. (GUTS)

• TipRanks·03/25 10:50

  Analysts Conflicted on These Healthcare Names: Fractyl Health, Inc. (GUTS), AbSci (ABSI) and Alnylam Pharma (ALNY)

• Benzinga·03/25 06:56

  Fractyl Health (GUTS) Stock Jumps 21% After Hours: Here's What You Should Know

• Seeking Alpha·03/24 22:55

  Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4

• TipRanks·03/24 20:35

  Fractyl Highlights Revita Progress and 2025 Financial Results

• Reuters·03/24 20:25

  Fractyl Health publishes Revita REMAIN-1 presentation highlighting about 70% reduction in post-GLP-1 weight regain

• Benzinga·03/24 20:11

  Fractyl Health Q4 EPS $(0.07) Beats $(0.19) Estimate

• Seeking Alpha·03/24 20:07

  Fractyl Health reports Q4 results

• Dow Jones·03/24 20:02

  *Fractyl Health 4Q Rev $0.00 >GUTS